Search Results

Displaying Results 2901-2925 of 20586 "'R'"

Jul 29, 2026, 14:19 ET Hexaware Reports Q2CY26 Revenue at USD 405.4 Mn, Up 6.1% YoY

innovating at remarkable speed, launching one new offering every month. This innovation forms the foundation for sustained growth in the AI world."R. Srikrishna, CEO"This was our first quarter with the ERP go-live which marks a major milestone in our transformation journey. We delivered industry-leading

More news about: Hexaware Technologies Limited


Jul 29, 2026, 13:14 ET GMP Biologics Market to Reach US$98.2 Bn by 2033 Accelerates with Biopharmaceutical Innovation - Persistence Market Research

market.Its leadership is supported by the world's largest biopharmaceutical research ecosystem, strong FDA regulatory framework, substantial pharmaceutical R&D investment, and the presence of leading biologics developers and CDMOs. Major companies including Thermo Fisher Scientific, Catalent, KBI Biopharma,

More news about: Persistence Market Research Pvt. Ltd.


Jul 29, 2026, 13:09 ET /C O R R E C T I O N -- Weihai Medison/

China, Weihai Medison combines a 2,000-square-meter Class-100K manufacturing base with the Medison Korea Joint Research Institute — a multidisciplinary R&D arm partnered with senior researchers from Seoul National and Yonsei universities and leading Korean research institutes. The VEMERIX portfolio centers

More news about: WEIHAI MEDISON (VEMERIX brand)


Jul 29, 2026, 12:07 ET Octapharma to build $1.5 billion state-of-the-art critical care manufacturing facility in Rock Hill, SC

countries across Immunotherapy, Hematology, and Critical Care. Octapharma has 190 plasma donation centers across the United States With seven R&D sites, five manufacturing facilities in Europe, and more than 200 plasma donation centers in the US and Europe, Octapharma has delivered trusted therapies

More news about: Octapharma


Jul 29, 2026, 10:31 ET Graves Ophthalmopathy Market Expected to Witness Rapid Expansion at a CAGR of 9% During the Forecast Period (2026-2036), Driven by the Recent Approval of Viridian's LUMVOA and the Launch of Emerging Therapies | DelveInsight

disease. The therapy is designed to inhibit the insulin-like growth factor-1 receptor (IGF-1R), a well-established driver of TED pathogenesis. Viridian is advancing Elegrobart as a potential best-in-class subcutaneous anti-IGF-1R treatment that can be self-administered at home using a low-volume autoinjector,

More news about: DelveInsight Business Research, LLP


Jul 29, 2026, 10:23 ET Celebrating Excellence: Elk + Elk Attorneys Recognized in the 2027 Ohio Super Lawyers and Rising Stars Lists

Elk + Elk who earned a place on the 2027 Ohio Super Lawyers list: Jay Kelley** John O'Neil** R. Craig McLaughlin** Phillip Kuri** Gary Cowan** Matthew Carty ~ Bill Price** Bill

More news about: ELK & ELK


Jul 29, 2026, 10:15 ET GaN Substrate Market worth $1.25 billion by 2032 - Exclusive Report by MarketsandMarkets™

aerospace & defense, telecommunications, AI data centers, industrial power systems, and electric vehicles. Investments in advanced semiconductor R&D, government initiatives supporting domestic chip manufacturing, and expanding deployment of 5G infrastructure are further driving the regional market.

More news about: MarketsandMarkets


Jul 29, 2026, 10:00 ET Tredence Positioned as a 'Leader' in AIM Research's Top AI Service Providers for Life Sciences & Healthcare PeMa Quadrant 2026

category-defining ability to build and scale agentic systems across healthcare and life sciences enterprises. These capabilities span next-generation R&D and clinical innovation, autonomous enterprise operations, supply chain transformation, and patient-centric care delivery modernization.

More news about: Tredence


Jul 29, 2026, 10:00 ET Tredence Positioned as a 'Leader' in AIM Research's Top AI Service Providers for Life Sciences & Healthcare PeMa Quadrant 2026

category-defining ability to build and scale agentic systems across healthcare and life sciences enterprises. These capabilities span next-generation R&D and clinical innovation, autonomous enterprise operations, supply chain transformation, and patient-centric care delivery modernization.

More news about: Tredence


Jul 29, 2026, 10:00 ET Becklin Holdings Welcomes Aviation Leaders, Enthusiasts, and Content Creators for Exclusive Event at Nail Spring Ranch

turbine-powered backcountry aircraft and watched it fly over the ranch before landing on Nail Spring Ranch's private runway. Powered by Turbotech's regenerative TP-R90 turboprop engine, the ULT is designed to pair turbine reliability and operational simplicity with fuel consumption comparable to a similarly sized piston

More news about: Becklin Holdings


Jul 29, 2026, 09:30 ET TerraCycle Launches Innovative Nicotine Vape Device Recycling Service, Creating a National Solution for One of America's Fastest-Growing Waste Streams

now, there has been no clear path to a scalable recycling solution," said Tom Szaky, Founder and CEO of TerraCycle. "Through the dedication of our R&D team, our operations and compliance experts, and the strategic investments made to grow TerraCycle, we are proud to deliver a national solution for

More news about: TerraCycle US Inc.


Jul 29, 2026, 09:11 ET Schlesinger Law Offices Obtains $5.605 Million Verdict for Newspaper Carrier Trapped in Condominium Elevator

at trial, she has been unable to return to work because of the physical and emotional injuries she suffered.Mardy was represented by Jonathan R. Gdanski, Steven J. Hammer and David Silverman of Schlesinger Law Offices, P.A.Lauren Berger, BoardroomPR

More news about: Schlesinger Law Offices, P.A.


Jul 29, 2026, 09:00 ET AU10TIX and Reality Defender Partner to Detect Deepfake Identity Fraud

enhancing trust, safety, and compliance for businesses worldwide. Founded in 2002 in the Netherlands, with offices in London, New York, Singapore, and R&D centers in Israel and Eastern Europe, AU10TIX safeguards the world's most trusted brands through world-class automation, sophisticated fraud

More news about: AU10TIX


Jul 29, 2026, 09:00 ET POSITIVE CHMP OPINION SUPPORTS BROADER USE OF AMGEN'S REPATHA® BEFORE A FIRST HEART ATTACK OR STROKE

10.4330/wjc.v18.i2.114960. PMID: 41694036; PMCID: PMC12897005.Data on File; Amgen, 2025.Data on File; Amgen, 2025.Ndumele, C. E., & Blumenthal, R. S. (2025). VESALIUS and the Anatomy of High-Risk Prevention. New England Journal of Medicine. 

More news about: Amgen


Jul 29, 2026, 08:49 ET LG Launches New Award-Winning UltraGear™ evo 5K2K Gaming Monitor Line-up

LG UltraGear™ evo G9 – The world's largest 5K2K 240Hz gaming monitor features a massive 52-inch curved display. With a 21:9 aspect ratio and 1000R curvature, it wraps around the user's field of vision while providing an ultra-smooth 240Hz refresh rate.LG UltraGear™ evo GX9 – An Innovation

More news about: LG


Jul 29, 2026, 08:39 ET As Consumer Demand Reshapes Food Innovation, a New Wave of Startups Reimagines How Consumers Experience Blueberries

ingredients, and fortified with important nutrients. Blueberry will be the first flavor to launch their new fruit snack line. They are represented by VP of R&D/FSQA Kelly Glynn.Clean-Label Beverages: 

More news about: U.S. Highbush Blueberry Council


Jul 29, 2026, 08:30 ET Lockton uruchamia globalną praktykę Data Centers & Digital Infrastructure

obliczeniowej i łączności cyfrowej.KANSAS CITY, Missouri, 29 lipca 2026 r. /PRNewswire/ -- Firma Lockton, największy na świecie niezależny prywatny broker ubezpieczeniowy, ogłosiła dziś uruchomienie globalnej praktyki Data

More news about: Lockton


Jul 29, 2026, 08:30 ET SUNON Unveils ErP 2026-Ready Green EC Fans to Power Next-Gen AI Infrastructure

protection to solve the friction between strict energy regulations and brutal operating conditions," says SUNON. "As ErP 2026 approaches, our in-house R&D ensures global clients can seamlessly transition to next-gen power architectures without sacrificing sustainability."Moving forward, SUNON will

More news about: SUNON


Jul 29, 2026, 08:30 ET Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma

said Feng Ren, PhD, co-CEO and Chief Scientific Officer of Insilico Medicine. "At Insilico, we are delivering strategies to revolutionize drug R&D at scale, and the generative AI advantage in efficiency is largely maintained or even enhanced through innovation-friendly schemes like the FTD. We

More news about: Insilico Medicine


Jul 29, 2026, 08:15 ET Silicom Reports Q2 2026 Results

(*) Adjustments related to share-based compensation expenses according to ASC topic 718 (SFAS 123 (R))

More news about: Silicom Ltd.


Jul 29, 2026, 07:01 ET METLEN signe un accord historique d'approvisionnement en gallium

stratégique.Cette avancée est le fruit des efforts de longue date en matière de recherche et d'innovation menés par les équipes internes de R&D de l'entreprise, basées dans le site industriel historique d'Aluminium of Greece, en collaboration avec le sous-secteur « Métaux critiques et rares

More news about: METLEN Energy & Metals PLC


Jul 29, 2026, 07:00 ET CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints

vascular inflammation. J Clin Invest. 2013;123(2):887-902.Kosuru R, et al. Rap1A controls store-operated calcium entry and lung inflammation via Orai1 regulation. Arterioscler Thromb Vasc Biol. 2024;44:2271-2287.Sutton R, Garg PK, Miller J, et al. Zegocractin for acute pancreatitis with systemic

More news about: CalciMedica, Inc.


Jul 29, 2026, 06:59 ET アブダビ文化観光局、グッゲンハイム・アブダビの2026年12月11日開館を発表6

は学習、創造性、文化交流における変革的な新しい機会を創出し、未来の世代が自らの可能性を探求するようインスピレーションを与えます。ここでは誰もが自分自身の居場所を見出し、美術館が語るストーリーの中に自分を重ね合わせ、世界中のアイデアや芸術的な声に触れることができます。」ソロモン・R・グッゲンハイム財団の館長兼CEOであるMariët Westermann博士は、次のように述べました。「グッゲンハイム財団は、アブダビ文化観光局との長年にわたるパートナーとして、壮大なスケールと高い志を持つ現代美術館の構築に参画できることを誇りに思い、大変嬉しく思っています。当美術館のコレ

More news about: Department of Culture and Tourism - Abu Dhabi


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.